BAM
Beaumont Asset Management’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-17,517
| Closed | -$444K | – | 74 |
|
|
2025
Q1 | $444K | Buy |
17,517
+528
| +3% | +$13.4K | 0.27% | 54 |
|
|
2024
Q4 | $451K | Buy |
16,989
+209
| +1% | +$5.55K | 0.26% | 50 |
|
|
2024
Q3 | $486K | Sell |
16,780
-70
| -0.4% | -$2.03K | 0.28% | 47 |
|
|
2024
Q2 | $471K | Buy |
+16,850
| New | +$471K | 0.3% | 49 |
|
|
2024
Q1 | – | Sell |
-25,465
| Closed | -$733K | – | 67 |
|
|
2023
Q4 | $733K | Sell |
25,465
-994
| -4% | -$28.6K | 0.52% | 41 |
|
|
2023
Q3 | $878K | Sell |
26,459
-113
| -0.4% | -$3.75K | 0.72% | 29 |
|
|
2023
Q2 | $975K | Sell |
26,572
-754
| -3% | -$27.7K | 0.74% | 33 |
|
|
2023
Q1 | $1.11M | Sell |
27,326
-1,824
| -6% | -$74.4K | 0.82% | 27 |
|
|
2022
Q4 | $1.49M | Buy |
29,150
+325
| +1% | +$16.7K | 1.09% | 22 |
|
|
2022
Q3 | $1.26M | Buy |
28,825
+269
| +0.9% | +$11.8K | 1% | 22 |
|
|
2022
Q2 | $1.5M | Buy |
28,556
+2,935
| +11% | +$154K | 1.13% | 20 |
|
|
2022
Q1 | $1.33M | Sell |
25,621
-478
| -2% | -$24.7K | 0.9% | 23 |
|
|
2021
Q4 | $1.54M | Buy |
26,099
+566
| +2% | +$33.4K | 1.03% | 19 |
|
|
2021
Q3 | $1.1M | Buy |
25,533
+1,849
| +8% | +$79.5K | 0.82% | 22 |
|
|
2021
Q2 | $927K | Buy |
23,684
+94
| +0.4% | +$3.68K | 0.71% | 27 |
|
|
2021
Q1 | $854K | Buy |
23,590
+669
| +3% | +$24.2K | 0.72% | 27 |
|
|
2020
Q4 | $843K | Buy |
22,921
+1,455
| +7% | +$53.5K | 0.76% | 25 |
|
|
2020
Q3 | $787K | Buy |
21,466
+222
| +1% | +$8.14K | 0.79% | 27 |
|
|
2020
Q2 | $694K | Buy |
21,244
+276
| +1% | +$9.02K | 0.73% | 32 |
|
|
2020
Q1 | $684K | Sell |
20,968
-84
| -0.4% | -$2.74K | 0.82% | 31 |
|
|
2019
Q4 | $824K | Buy |
+21,052
| New | +$824K | 0.79% | 42 |
|